Skip to content

Evaluation of the PillCam ESO Capsule in the Detection of Esophageal Varices

Evaluation of the PillCam ESO Capsule in the Detection of Esophageal Varices in Patients with liver disease- known or suspected for esophageal varices

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12605000669695
Enrollment
30
Registered
2005-10-20
Start date
2005-11-15
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

This multi center study will assess the performance of the PillCam ESO Esophageal Capsule and the Given Diagnostic System in the diagnosis of esophageal varices as compared to EGD.

Sponsors

Given Imaging Ltd., New Industrial Park, Yoqneam, Israel
Lead SponsorCommercial sector/Industry

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1.Patient Has prior endoscopic confirmation of esophageal varices and is undergoing surveillance endoscopy orHas signs/symptoms of chronic liver disease, without previous diagnosis of esophageal varices, with clinical indication to undergo esophagoscopy (or EGD) 2.Patient agrees and signs the Informed Consent Form. 3. Patient is prepared to undergo upper GI endoscopy.

Exclusion criteria

1. Patient has dysphagia2. Patient has known Zenkers Diverticulum3.Patient went through previous endoscopic treatment of esophageal varices.4. Patient is known or is suspected to suffer from intestinal obstruction.5. Patient has a cardiac pacemakers or other implanted electro medical devices.6.Female patient is pregnant 7.Patient is expected to undergo MRI examination within 7 days after ingestion of the capsule.8.Patient has had a prior abdominal surgery of the gastrointestinal tract (other than uncomplicated appendectomy or uncomplicated cholecystectomy) 9. Patient has any condition, which precludes compliance with study and/or device instructions.10.Patient suffers from life threatening conditions11.Patient is currently participating in another clinical study.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026